U.S. Army Medical Research and Development Command: all 153 studies

Page 2 of 2. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) VaccineStatus unknownNCT02466750Phase 2
• Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US AdultsCompletedNCT02421367Phase 1/2
• ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ - 3-Dose Primary Series With BoostWithdrawnNCT02386150Phase 1
• IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With BoostWithdrawnNCT02385825Phase 1
• Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus StrainCompletedNCT02372175Phase 1
• TDENV PIV and LAV Dengue Prime-boost StrategyCompletedNCT02239614Phase 1
• Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve AdultsCompletedNCT02174978Phase 1
• Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Full Trial)WithdrawnNCT02125591Not applicable
• Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Pilot Trial)WithdrawnNCT02109198Not applicable
• Safety and Immunogenicity of Q Fever VaccineWithdrawnNCT02092142Phase 2
• Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS)CompletedNCT02018250Phase 1
• Immunization Via Mosquito Bite With Radiation-attenuated SporozoitesCompletedNCT01994525Phase 1
• Study of Immune Responses Induced by a HIV VaccineStatus unknownNCT01933685Phase 2
• Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/EStatus unknownNCT01931358Phase 2
• Challenge Study of an ETEC VaccineCompletedNCT01922856Phase 2
• A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic ReagentsWithdrawnNCT01843491Phase 1
• A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)CompletedNCT01702857Phase 1
• Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant BacteriaNo longer availableNCT01659515
• Paromomycin for Individuals With Uncomplicated Cutaneous LeishmaniasisNo longer availableNCT01641796
• Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,SCompletedNCT01556945Phase 1/2
• The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome in Trauma PatientsStatus unknownNCT01547013
• Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue DiseaseCompletedNCT01502735Phase 1
• Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue DiseaseCompletedNCT01502358Phase 1
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA VaccinesCompletedNCT01502345Phase 1
• Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144Status unknownNCT01435135Phase 2
• Reference Values for Non-invasive Hydration Status Markers H10-14CompletedNCT01387529
• Safety Study of Recombinant Vaccine to Prevent ETEC DiarrheaCompletedNCT01382095Phase 1
• Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human PerformanceCompletedNCT01194336
• Western Equine Encephalitis Vaccine, InactivatedCompletedNCT01159561Phase 1
• Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment FacilitiesWithdrawnNCT00992693Phase 2
• Clinical Trial for the Development of a Safe Malaria Challenge Model That Can be Reproduced in HumansCompletedNCT00935623Phase 1
• Clinical Trial for Malaria Vaccines to Test for Safety, Immune Response and Protection Against MalariaCompletedNCT00870987Phase 1/2
• Safety and Immunogenicity Study of Rift Valley Fever Vaccine, InactivatedCompletedNCT00869713Phase 2
• Ribavirin for Hemorrhagic Fever With Renal Syndrome in GermanyWithdrawnNCT00868946Phase 2
• Continued Safety and Immunogenicity Study of a Live Francisella Tularensis VaccineStatus unknownNCT00787826Phase 2
• Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria InfectionCompletedNCT00761020Not applicable
• A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in KenyaCompletedNCT00666380Phase 1
• Ribavirin for Hemorrhagic Fever With Renal SyndromeWithdrawnNCT00623168Phase 2
• Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis VaccineStatus unknownNCT00582504Phase 2
• Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83Status unknownNCT00582088Phase 2
• Cosmetic Outcome of Leishmaniasis Scar After WR279396 ApplicationCompletedNCT00490230Not applicable
• A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 VaccineCompletedNCT00412477Phase 1
• Questionnaire Study for Gynecological Cancer SurvivorsStatus unknownNCT00391664
• Questionnaire Study to Assess Quality of Life After Treatment of FibroidsStatus unknownNCT00390494
• A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in AdultsCompletedNCT00385047Phase 1/2
• Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected AdultsCompletedNCT00376090Phase 1
• Tissue Bank of Biological Specimens From Patients With Gynecologic DiseaseStatus unknownNCT00299481
• Study of the Safety of Intravenous ArtesunateCompletedNCT00292929Phase 1
• Vietnam Head Injury Study - Phase IIICompletedNCT00132249
• Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging StudyWithdrawnNCT00124865Phase 1
• Phase 1 meCS6 + LT(R192G) Vaccine StudyWithdrawnNCT00090688Phase 1
• Invaplex 50 Vaccine Dose-RangingCompletedNCT00082069Phase 1
• Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent MalariaCompletedNCT00075049Phase 1/2

← U.S. Army Medical Research and Development Command overview and focus areas